Bioethics, Ltd. (BOTH) financial statements (2022 and earlier)

Company profile

Business Address 1661 LAKEVIEW CIRCLE
OGDEN, UT 84403
State of Incorp. NV
Fiscal Year End December 31
SIC 677 - Blank Checks (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 193226649
Cash and cash equivalents 193226649
Receivables   21  
Other undisclosed current assets   (2)2 25
Total current assets: 193246675
Noncurrent Assets
Property, plant and equipment 11    
Other undisclosed noncurrent assets (1)(1)111 
Total noncurrent assets: 01111 
TOTAL ASSETS: 193256775
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 925812   
Accounts payable 5438    
Accrued liabilities 392012   
Debt 150151    
Derivative instruments and hedges, liabilities 32     
Due to related parties 183152    
Other undisclosed current liabilities 221428918918776
Total current liabilities: 48037530018918776
Noncurrent Liabilities
Total liabilities: 48037530018918776
Stockholders' equity
Stockholders' equity attributable to parent, including: (479)(366)(268)(184)(120)(1)
Common stock 11111116116116
Additional paid in capital 500484480385385385
Accumulated deficit (980)(861)(759)(686)(621)(503)
Other undisclosed stockholders' equity attributable to parent     (0)(0)
Other undisclosed stockholders' equity     00
Total stockholders' equity: (479)(366)(268)(184)(120)(1)
TOTAL LIABILITIES AND EQUITY: 193256775

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Operating expenses (75)(70)(54)(48)(50)(47)
Operating loss: (75)(70)(54)(48)(50)(47)
Nonoperating income (expense) (44)(32)  4 
Investment income, nonoperating     4 
Interest and debt expense (44)(32)20167349
Income (loss) from continuing operations before equity method investments, income taxes: (163)(134)(34)(32)272
Other undisclosed income from continuing operations before income taxes 4432    
Income (loss) before gain (loss) on sale of properties: (119)(102)(34)(32)272
Other undisclosed net loss   (39)(32)(146)(98)
Net loss available to common stockholders, diluted: (119)(102)(74)(64)(119)(96)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (119)(102)(74)(64)(119)(96)
Comprehensive loss, net of tax, attributable to parent: (119)(102)(74)(64)(119)(96)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: